Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 494 entries
View as:

Avonex PEN Satisfaction and Patients Experience Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT01366040 Org: User:
Start: 06/30/11 End: 05/31/12 Due: 05/31/13

Effect of Itraconazole on the Pharmacokinetics of BIIB074

Phase: N/A Priority: Normal
NCT ID: NCT02698267 Org: User:
Start: 02/29/16 End: 04/30/16 Due: 04/30/17

An Observational Study of Aducanumab-avwa in Participants With Alzheimer's Disease in the US

Phase: N/A Priority: Normal
NCT ID: NCT05097131 Org: User:
Start: 11/18/21 End: 05/20/22 Due: 05/20/23

JC-virus (JCV) Epidemiology in Multiple Sclerosis (MS)

Phase: N/A Priority: Normal
NCT ID: NCT01185717 Org: User:
Start: 09/30/10 End: 06/30/12 Due: 06/30/13

Real World Analysis on Lymphocyte Reconstitution After Lymphopenia in Participants Treated by Tecfidera

Phase: N/A Priority: Normal
NCT ID: NCT04756687 Org: User:
Start: 03/10/21 End: 06/15/21 Due: 06/15/22

Transition to Peginterferon Beta-1a (BIIB017) From Subcutaneous Interferon Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02234869 Org: User:
Start: 10/31/14 End: 03/31/18 Due: 03/31/19

A Study to Learn How BIIB141 (Omaveloxolone) Affects the Health of Participants With Friedrich's Ataxia Who Took it During Pregnancy and/or During Breastfeeding and About the Health of Their Babies

Phase: N/A Priority: Normal
NCT ID: NCT06628687 Org: User:
Start: 10/26/26 End: 04/30/35 Due: 04/30/36

Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03318523 Org: User:
Start: 01/10/18 End: 04/29/21 Due: 04/29/22

Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02269930 Org: User:
Start: 10/31/14 End: 12/31/14 Due: 12/31/15

RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD

Phase: N/A Priority: Normal
NCT ID: NCT02128113 Org: User:
Start: 05/31/14 End: 04/30/15 Due: 04/30/16

MATRIX: Measuring Neutralizing Antibodies in the Patients Treated With Interferon Beta 1a IM, in Mexico and Colombia

Phase: N/A Priority: Normal
NCT ID: NCT01556685 Org: User:
Start: 03/31/11 End: - Due: -

Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT00391066 Org: User:
Start: 11/30/06 End: 12/31/10 Due: 12/31/11

A Multiple Dose Safety Study of PEG-IFN in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02125578 Org: User:
Start: 03/31/08 End: 05/31/08 Due: 05/31/09

Open-Label Safety Extension Study of Avonex

Phase: N/A Priority: Normal
NCT ID: NCT00915460 Org: User:
Start: 09/30/99 End: 07/31/03 Due: 07/31/04

Pharmacokinetics Profile Study of BG00012 Standard Formulation and BG00012 Active Pharmaceutical Ingredient

Phase: N/A Priority: Normal
NCT ID: NCT01069913 Org: User:
Start: 10/31/09 End: 01/31/10 Due: 01/31/11

A Pharmacokinetic Study of Omaveloxolone in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03664453 Org: User:
Start: 10/29/18 End: 11/20/18 Due: 11/20/19

Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00550849 Org: User:
Start: 04/30/07 End: 11/30/07 Due: 11/30/08

Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers Including Absolute Bioavailability and Food Effect

Phase: N/A Priority: Normal
NCT ID: NCT02071121 Org: User:
Start: 12/31/13 End: 09/30/14 Due: 09/30/15

A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON

Phase: N/A Priority: Normal
NCT ID: NCT03918447 Org: User:
Start: 05/29/19 End: 08/08/23 Due: 08/08/24

Absolute Bioavailability of a Single, Fixed Subcutaneous Dose of Aducanumab in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02782975 Org: User:
Start: 05/31/16 End: 11/30/16 Due: 11/30/17

RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE

Phase: N/A Priority: Normal
NCT ID: NCT02142959 Org: User:
Start: 06/30/14 End: 04/30/15 Due: 04/30/16

A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN)

Phase: N/A Priority: Normal
NCT ID: NCT04702997 Org: User:
Start: 02/09/21 End: 11/23/21 Due: 11/23/22

Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019

Phase: N/A Priority: Normal
NCT ID: NCT01797965 Org: User:
Start: 02/15/13 End: 09/24/18 Due: 09/24/19

A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT02201849 Org: User:
Start: 07/31/14 End: 12/31/14 Due: 12/31/15

A Study to Evaluate Safety, Tolerability, and Distribution of a Microdose of Radiolabeled BIIB067 (99mTc-MAG3-BIIB067) Co-administered With BIIB067 (Tofersen) to Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03764488 Org: User:
Start: 12/20/18 End: 07/10/21 Due: 07/10/22